GE HealthCare Technologies Inc.
GEHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $5 | $5 |
| % Growth | 2.7% | 4.8% | -10.2% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $3 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 38.7% | 39.7% | 42.1% | 42.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 12.7% | 13.1% | 13.2% | 15.1% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $1 | $1 |
| % Margin | 8.7% | 9.7% | 11.8% | 13.5% |
| EPS | 0.98 | 1.06 | 1.23 | 1.58 |
| % Growth | -7.5% | -13.8% | -22.2% | – |
| EPS Diluted | 0.98 | 1.06 | 1.23 | 1.57 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 17.5% | 17.5% | 19.7% | 20.4% |